Jefferies Financial Group

Selected news for the capital firm - Jefferies Financial Group, collected since 4/2019. Recent stories appear in Daily Political and dispatchtribunal.com. This capital firm shares healthcare news with Medical Research, GlaxoSmithKline, Fresenius Medical Care, Amarin, Healthcare Services Group and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/23/2021 Analysts Offer Predictions for PRA Health Sciences, Inc.'s Q1 2021 Earnings (NASDAQ:PRAH) | Daily Political Daily Political PRA Health Sciences, Inc. (NASDAQ:PRAH) – Analysts at Jefferies Financial Group dropped their Q1 2021 earnings estimates for PRA Health Sciences in a report issued on Tuesday, April 20th. Jefferies Financial Group analyst D. Windley now expects that the medical research company will post earnings of $1.11 per share for the quarter, down from their previous forecast of $1.12. Jefferies Financial Group has a “Hold” rating on the ...
4/23/2021 Analysts Offer Predictions for PRA Health Sciences, Inc.'s Q1 2021 Earnings (NASDAQ:PRAH) Mayfield Recorder Analysts Offer Predictions for PRA Health Sciences, Inc.’s Q1 2021 Earnings (NASDAQ:PRAH) Posted by Charles Blunt on Apr 23rd, 2021PRA Health Sciences, Inc. (NASDAQ:PRAH) – Jefferies Financial Group cut their Q1 2021 earnings estimates for shares of PRA Health Sciences in a research report issued on Tuesday, April 20th. Jefferies Financial Group analyst D. Windley now expects that the medical research company will post earnings per ...
4/23/2021 Jefferies Financial Group Analysts Decrease Earnings Estimates for PRA Health Sciences, Inc. (NASDAQ:PRAH) - Transcript Daily transcriptdaily.com PRA Health Sciences, Inc. (NASDAQ:PRAH) – Equities researchers at Jefferies Financial Group dropped their Q2 2021 earnings per share (EPS) estimates for shares of PRA Health Sciences in a research report issued to clients and investors on Tuesday, April 20th. Jefferies Financial Group analyst D. Windley now forecasts that the medical research company will post earnings of $1.21 per share for the quarter, down from their previous forecast of ...
4/23/2021 Jefferies Financial Group Analysts Decrease Earnings Estimates for PRA Health Sciences, Inc. (NASDAQ:PRAH) - Stock Observer thestockobserver.com PRA Health Sciences, Inc. (NASDAQ:PRAH) – Investment analysts at Jefferies Financial Group lowered their Q2 2021 earnings per share estimates for PRA Health Sciences in a note issued to investors on Tuesday, April 20th. Jefferies Financial Group analyst D. Windley now anticipates that the medical research company will post earnings per share of $1.21 for the quarter, down from their prior forecast of $1.23. Jefferies Financial Group currently has ...
4/23/2021 Q2 2021 EPS Estimates for Quest Diagnostics Incorporated Cut by Analyst (NYSE:DGX) baseballnewssource.com Q2 2021 EPS Estimates for Quest Diagnostics Incorporated Cut by Analyst (NYSE:DGX) Posted by Chris Copeland on Apr 23rd, 2021 TweetQuest Diagnostics Incorporated (NYSE:DGX) – Equities researchers at Jefferies Financial Group reduced their Q2 2021 earnings per share estimates for shares of Quest Diagnostics in a research note issued on Tuesday, April 20th. Jefferies Financial Group analyst B. Tanquilut now expects that the medical research company will ...
4/23/2021 IQVIA Holdings Inc. Expected to Earn Q2 2021 Earnings of $1.76 Per Share (NYSE:IQV) Dakota Financial News IQVIA Holdings Inc. (NYSE:IQV) – Analysts at Jefferies Financial Group increased their Q2 2021 earnings per share estimates for shares of IQVIA in a note issued to investors on Tuesday, April 20th. Jefferies Financial Group analyst D. Windley now forecasts that the medical research company will post earnings of $1.76 per share for the quarter, up from their prior forecast of $1.71. Jefferies Financial Group also issued estimates for ...
4/23/2021 Alphabet (NASDAQ:GOOG) Price Target Raised to $2,575.00 slatersentinel.com ... 2,450.00 target price for the company. Morgan Stanley increased their price target on shares of Alphabet from $2,050.00 to $2,200.00 and gave the company an overweight rating in a report on Wednesday, February 3rd. Jefferies Financial Group increased their target price on Alphabet from $2,150.00 to $2,400.00 in a research note on Wednesday, February 3rd. Finally, Citigroup restated a buy rating on shares of Alphabet in a research note on ...
4/23/2021 CRISPR Therapeutics (NASDAQ:CRSP) Raised to “Buy” at Jefferies Financial Group | Daily Political Daily Political CRISPR Therapeutics (NASDAQ:CRSP) was upgraded by Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released on Wednesday, Analyst Price Targets reports. The brokerage currently has a $172.00 target price on the stock. Jefferies Financial Group’s target price points to a potential upside of 36.63% from the stock’s current price.Several other research firms also recently weighed in on CRSP. JMP ...
4/23/2021 Barclays Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $160.00 - Ticker Report Ticker Report ... Wednesday, February 17th. Chardan Capital boosted their price target on shares of CRISPR Therapeutics from $166.00 to $175.00 and gave the company a “buy” rating in a report on Wednesday, February 17th. Finally, Jefferies Financial Group raised shares of CRISPR Therapeutics from a “hold” rating to a “buy” rating and set a $172.00 price target on the stock in a report on Wednesday. Three research analysts have ...
4/23/2021 Q1 2021 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Increased by Analyst - Transcript Daily transcriptdaily.com CRISPR Therapeutics AG (NASDAQ:CRSP) – Stock analysts at Jefferies Financial Group boosted their Q1 2021 EPS estimates for shares of CRISPR Therapeutics in a note issued to investors on Wednesday, April 21st. Jefferies Financial Group analyst M. Raycroft now expects that the company will earn ($1.44) per share for the quarter, up from their prior forecast of ($1.47). Jefferies Financial Group currently has a “Buy” rating and a ...
4/23/2021 Oppenheimer Comments on CRISPR Therapeutics AG's Q3 2021 Earnings (NASDAQ:CRSP) - Ticker Report Ticker Report ... 7.06) EPS, FY2023 earnings at ($4.38) EPS, FY2024 earnings at ($4.69) EPS and FY2025 earnings at $3.35 EPS.Get CRISPR Therapeutics alerts: CRSP has been the topic of a number of other research reports. Jefferies Financial Group upgraded shares of CRISPR Therapeutics from a “hold” rating to a “buy” rating and set a $172.00 price objective on the stock in a research note on Wednesday. Needham & Company LLC ...
4/23/2021 PRA Health Sciences (NASDAQ:PRAH) Reaches New 52-Week High at $163.17 - Ticker Report Ticker Report ... March 15th. Robert W. Baird lowered PRA Health Sciences from an “outperform” rating to a “neutral” rating and set a $165.00 target price on the stock. in a research report on Tuesday. Jefferies Financial Group lowered PRA Health Sciences from a “buy” rating to a “hold” rating in a research report on Thursday, February 25th. Finally, Mizuho increased PRA Health Sciences from $110.00 to $155.00 in ...
4/23/2021 PRA Health Sciences (NASDAQ:PRAH) Hits New 52-Week High at $163.17 | Daily Political Daily Political ... on PRAH shares. Robert W. Baird downgraded PRA Health Sciences from an “outperform” rating to a “neutral” rating and set a $165.00 price target for the company. in a report on Tuesday. Jefferies Financial Group downgraded PRA Health Sciences from a “buy” rating to a “hold” rating in a report on Thursday, February 25th. KeyCorp reiterated a “sector weight” rating on shares of PRA Health ...
4/23/2021 PRA Health Sciences (NASDAQ:PRAH) Sets New 52-Week High at $163.17 - Watch List News watchlistnews.com ... stock traded as high as $163.17 and last traded at $163.06, with a volume of 310 shares. The stock had previously closed at $162.68.PRAH has been the topic of several research analyst reports. Jefferies Financial Group cut shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a research note on Thursday, February 25th. Zacks Investment Research raised shares of PRA Health Sciences ...
4/23/2021 Ikena Oncology (NASDAQ:IKNA) Shares Gap Down to $19.94 rivertonroll.com ... IKNA has been the subject of several recent analyst reports. William Blair initiated coverage on shares of Ikena Oncology in a research note on Tuesday. They set an “outperform” rating for the company. Jefferies Financial Group began coverage on shares of Ikena Oncology in a report on Tuesday. They set a “buy” rating on the stock. Finally, Credit Suisse Group assumed coverage on shares of Ikena Oncology in ...
4/23/2021 Jefferies Financial Group Analysts Decrease Earnings Estimates for Syneos Health, Inc. (NASDAQ:SYNH) rivertonroll.com Jefferies Financial Group Analysts Decrease Earnings Estimates for Syneos Health, Inc. (NASDAQ:SYNH) Posted by Michael Baxter on Apr 23rd, 2021 TweetSyneos Health, Inc. (NASDAQ:SYNH) – Equities researchers at Jefferies Financial Group reduced their Q2 2021 earnings per share estimates for shares of Syneos Health in a note issued to investors on Tuesday, April 20th. Jefferies Financial Group analyst D. Windley now anticipates that the company will earn ...
4/23/2021 SBA Communications (NASDAQ:SBAC) Given New $321.00 Price Target at Morgan Stanley | Daily Political Daily Political ... research note issued to investors on Monday, PriceTargets.com reports. They currently have an equal weight rating on the technology company’s stock.A number of other research firms also recently issued reports on SBAC. Jefferies Financial Group began coverage on SBA Communications in a research note on Monday. They set a buy rating and a $335.00 price target for the company. Zacks Investment Research upgraded SBA Communications from a sell ...
4/22/2021 Brokers Set Expectations for Ikena Oncology, Inc.'s Q1 2021 (NASDAQ:IKNA) Daily Political Ikena Oncology, Inc. (NASDAQ:IKNA) – Equities research analysts at Jefferies Financial Group issued their Q1 2021 earnings per share (EPS) estimates for Ikena Oncology in a research note issued to investors on Tuesday, April 20th. Jefferies Financial Group analyst K. Shi anticipates that the company will earn ($0.13) per share for the quarter. Jefferies Financial Group currently has a “Buy” rating on the stock. Jefferies Financial Group also ...
4/20/2021 FY2021 Earnings Estimate for Smith & Nephew plc (NYSE:SNN) Issued By Jefferies Financial Group theenterpriseleader.com FY2021 Earnings Estimate for Smith & Nephew plc (NYSE:SNN) Issued By Jefferies Financial Group Posted by Maurice Goldstein on Apr 20th, 2021Smith & Nephew plc (NYSE:SNN) – Analysts at Jefferies Financial Group issued their FY2021 earnings per share (EPS) estimates for shares of Smith & Nephew in a research note issued on Wednesday, April 14th. Jefferies Financial Group analyst K. Lee expects that the medical equipment provider will post earnings ...
4/19/2021 Oppenheimer Trims Molecular Templates (NASDAQ:MTEM) Target Price to $13.00 rivertonroll.com ... Tuesday, February 23rd. UBS Group began coverage on shares of Molecular Templates in a research report on Monday, February 1st. They set a neutral rating and a $13.00 target price for the company. Finally, Jefferies Financial Group boosted their target price on shares of Molecular Templates from $18.00 to $20.00 in a research report on Tuesday, April 6th. Get Molecular Templates alerts:MTEM opened at $8.12 on Thursday. The company ...